Tags » CVP
Most Accessed Article – Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption Inhibition – Current Vascular Pharmacology
Journal: Current Vascular Pharmacology
Author(s): V. Tsimihodimos, T.D. Filippatos, S. Filippas-Ntekouan, M. Elisaf.
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are a new class of antidiabetic drugs that inhibit glucose and sodium reabsorption at proximal tubules. 173 more words